Metabolomics reveals new metabolic perturbations in children with type 1 diabetes.
Alfonso GalderisiPaola PirilloVittoria MoretMatteo StoccheroAntonina GucciardiGiorgio PerilongoCarlo MorettiCarlamaria MonciottiGiuseppe GiordanoEugenio BaraldiPublished in: Pediatric diabetes (2017)
T1D profoundly disrupts the metabolome of pediatric patients. The excess of cortisol and aldosterone may contribute to the development of macrovascular complications in adulthood, while the increase of tryptophan derivates may have a role in neuronal damage associated to hyperglycemia. Determinants of such findings, other than HbA1c, should be explored.